Glaxosmithkline Regulatory News (GSK)

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan

Period of return:

From:

1 November 2023

To:

30 April 2024

Balance of unallotted securities under scheme(s) from previous return:

271,307

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

155,789

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

115,518

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 November 2023

To:

30 April 2024

Balance of unallotted securities under scheme(s) from previous return:

506,598

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

2,000,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,833,574

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

673,024

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2022

Period of return:

From:

1 November 2023

To:

30 April 2024

Balance of unallotted securities under scheme(s) from previous return:

999,109

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

3,852

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

995,257

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000